Loading company…
Neupulse develops wearable devices and an app for non-drug management of Tourette Syndrome.
Founded in Nottingham, UK, in 2021, Neurotherapeutics Ltd., doing business as Neupulse, develops non-drug treatments for Tourette Syndrome. Its wearable wrist device delivers gentle median nerve stimulation, and its Neutrack app monitors symptoms and possible influences. In February 2026, the company raised GBP 3 million led by Eos, with Mercia Ventures participating, to support product development, regulatory progress, and early commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in